Delivery Order SPE2DB24D1104-SPE2DB24FXXU7
Award Date
5/8/24
Potential Completion Date
5/9/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Biktarvy 50-200-25 mg tablets in 30-count packages. The $10,172.22 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 25, 2024. Amerisourcebergen holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,966.82 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication. The contract has an ultimate completion date of August 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $46,746.77 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Biktarvy 50-200-25 mg tablet. The contract has a performance period through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. In addition, Amerisourcebergen Drug Corp holds an...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $29,558.37, is for the delivery of Biktarvy 50-200-25 mg tablet medication under a Firm Fixed Price Delivery Order contract. The contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $38,888.67 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Biktarvy 50-200-25 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Biktarvy 50-200-25 mg tablet in quantities of 30 per unit. The $5,036.04 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 24, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Biktarvy 50-200-25 mg tablets. The contract has a potential value of $9,878.78 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award, valued at $10,807.48, has an ultimate completion date of June 28, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $78,159.94, is a delivery order for Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of December 5, 2024 and is a firm fixed price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablets. The award amount is $10,892.86 with an ultimate completion date of April 25, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...